Do the recently modified pacemaker guidelines for neurocardiogenic syncope also apply to young patients? Analysis based on five-year follow-up of Israeli soldiers with syncope and a positive tilt test

Cardiology

Volumn 102, Issue 4, 2004, Pages 200-205

  Wagshal, Alan B ^a   Weinstein, Jean Marc ^a   Weinstein, Orly ^b   Zeldetz, Vladimir ^a   Damri, Esther ^a   Ilia, Reuven ^a   Katz, Amos ^a  

^a BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

^b Army Medical Services   (Israel)

Author keywords

Neurocardiogenic syncope; Pacing guidelines; Tilt table testing; Vasovagal syncope

Indexed keywords

AGE DISTRIBUTION; ARTIFICIAL HEART PACEMAKER; ASYSTOLE; DATA ANALYSIS; DISEASE CLASSIFICATION; FOLLOW UP; HIGH RISK PATIENT; HUMAN; INFORMATION RETRIEVAL; MEDICAL ASSESSMENT; MEDICAL RECORD; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW; SOLDIER; SYNCOPE; TILT TABLE TEST; TREATMENT INDICATION;

ADOLESCENT; ADULT; AGE FACTORS; CARDIAC PACING, ARTIFICIAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; PATIENT SELECTION; PRACTICE GUIDELINES; RECURRENCE; RETROSPECTIVE STUDIES; SYNCOPE, VASOVAGAL; TILT-TABLE TEST; TREATMENT OUTCOME;

EID: 5644258231     PISSN: 00086312     EISSN: None     Source Type: Journal    
DOI: 10.1159/000081011     Document Type: Review

References (33)

1. Gregoratos G, Abrams J, Epstein AAE, Freedman RA, Haeys DL, Hlatky MA, Kerber RE, Naccarelli GV, Schoenfeld MH, Silka MJ, Winters SL, Gibbons RJ, Antman EM, Alpert JS, Gregoratos G, Hiratzka LF, Faxon DP, Jacobs AK, Fuster V, Smith SC Jr; American College of Cardiology/American Heart Association Task Force on Practice Guidelines/North American Society for Pacing and Electrophysiology Committee to Update the 1998 Pacemaker Guidelines: ACC/AHA/NASPE 2002 guideline update for implantation of cardiac pacemakers and antiarrhythmia devices: Summary article: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/NASPE Committee to Update the 1998 Pacemaker Guidelines). Circulation 2002;106:2145-2161.
2. Benditt DG, Ferguson DW, Grubb BP, Kapoor WN, Kugler J, Lerman BB, Maloney JD, Raviele A, Ross B, Sutton R, Wolk MJ, Wood DL: Tilt table testing for assessing syncope. American College of Cardiology. J Am Coll Cardiol 1996;28:263-275.
3. Grubb BP, Karas B: Diagnosis and management of neurocardiogenic syncope. Curr Opin Cardiol 1998;13:29-35.
4. Fitzpatrick A, Theodorakis G, Vardas P, Kenny RA, Travill CM, Ingram A, Sutton R: The incidence of malignant vasovagal syndrome in patients with recurrent syncope. Eur Heart J 1991;12:389-394.
5. Brignole M, Menozzi C, Gianfranchi L, Lolli G, Bottoni N, Oddone D: A controlled trial of acute and long-term medical therapy in tilt-induced neurally mediated syncope. Am J Cardiol 1992;70:339-342.
6. Natale A, Geiger MJ, Maglio C, Newby KH, Dhala A, Akhtar M, Sra J: Recurrence of neurocardiogenic syncope without pharmacologic interventions. Am J Cardiol 1996;77:1001-1003.
7. Sheldon R, Rose S, Flanagan P, Koshman ML, Killam S: Risk factors for syncope recurrence after a positive tilt-table test in patients with syncope. Circulation 1996;93:973-981.
8. Grimm W, Degenhardt M, Hoffman J, Menz V, Wirths A, Maisch B: Syncope recurrence can better be predicted by history than by head-up tilt testing in untreated patients with suspected neurally mediated syncope. Eur Heart J 1997;18:1465-1469.
9. Baron-Esquivias G, Pedrote A, Cayuela A, Valle JI, Fernandex JM, Arana E, Fernandex M, Morales F, Burgos J, Martinez-Rubio A: Long-term outcome of patients with asystole induced by head-up tilt test. Eur Heart J 2002;23:483-489.
10. Kouakam C, Vaksmann G, Pachy E, LaCrois D, Rey C, Kacet S: Long-term follow-up of children and adolescents with syncope: Predictors of syncope recurrence. Eur Heart J 2001;22:1618-1625.
11. Sutton R, Brignole M, Menozzi C, Raviele A, Alboni P, Giana P, Moya A: Dual-chamber pacing in the treatment of neurally mediated tilt-positive cardioinhibitory syncope: Pacemaker versus no therapy: A multicenter randomized study. The Vasovagal Syncope International Study (VASIS) Investigators. Circulation 2000;102:294-299.
12. Madrid AH, Ortega J, Rebollo JG, Manzana JG, Segovia JG, Sanc A, Pena G, Moro C: Lack of efficacy of atenolol for the prevention of neurally mediated syncope in a highly symptomatic population: A prospective, double-blind, randomized and placebo-control study. J Am Coll Cardiol 2001;37:554-559.
13. Mahanonda N, Bhuripanyo K, Kangagate C: Randomized double-blind, placebo-controlled trial of oral atenolol in patients with unexplained syncope and positive upright tilt table test results. Am Heart J 1995;130:1250-1253.
14. Flevari P, Livanis EG, Theodorakis GN, Zarvalis E, Mesiskli T, Kremastinos DT: Vasovagal syncope: A prospective, randomized, crossover evaluation of the effect of propranolol, nadolol, and placebo on syncope recurrence and patients' well-being. J Am Coll Cardiol 2002;40:499-504.
15. Sra JS, Hazayeri MR, Avitall B, Dhala A, Deshpande S, Blanck Z, Akhtar M: Comparison of cardiac pacing with drug therapy in the treatment of neurocardiogenic (vasovagal) syncope with bradycardia or asystole. N Engl J Med 1993;328:1085-1090.
16. Petersen MEV, Chamberlain-Webber R, Fitzpatrick AP, Ingram A, Williams T, Sutton R: Permanent pacing for cardioinhibitory malignant vasovagal syndrome. Br Heart J 1994;71:274-281.
17. Benditt DG, Sutton R, Gammage MD, Markowitz T, Gorski J, Nygaard GA, Fetter J: Clinical experience with Thera DR rate-drop response pacing algorithm in carotid sinus syndrome and vasovagal syncope. The International Rate-Drop Investigators Group. Pacing Clin Electrophysiol 1997;20:832-839.
18. Sheldon R, Koshman ML, Wilson W, Kieser T, Rose S: Effect of dual-chamber pacing with automatic rate-drop sensing on recurrent neurally mediated syncope. Am J Cardiol 1998;81:158-162.
19. Ammirati F, Colivicchi F, Santini M; Syncope Diagnosis and Treatment Study Investigators: Permanent cardiac pacing versus medical treatment for the prevention of recurrent vasovagal syncope: A multicenter, randomized, controlled trial. Circulation 2001;104:52-57.
20. Connolly SJ, Sheldon R, Roberts RS, Gent M: The North American Vasovagal Pacemaker Study (VPS). A randomized trial of permanent cardiac pacing for the prevention of vasovagal syncope. J Am Coll Cardiol 1999;33:16-20.
21. Estes NAM III, Link MS, Cannom D, Naccarelli GV, Prystowsky EN, Maron BJ, Olshansky B; Expert Consensus Conference on Arrhythmias in the Athlete of the North American Society of Pacing and Electrophysiology: Report of the NASPE policy conference on arrhythmias and the athlete. J Cardiovasc Electrophysiol 2001;12:1208-1219.
22. Zipes DP, Garson A Jr: 26th Bethesda Conference: Recommendations for determining eligibility for competition in athletes with cardiovascular abnormalities. Task Force 6: Arrhythmias. J Am Coll Cardiol 1994;24:892-899.
23. Grubb B, Temesy-Armos P, Samoil D, Wolfe DA, Hahn H, Elliot L: Tilt table testing in the evaluation and management of athletes with recurrent exercise-induced syncope. Med Sci Sports Exerc 1992;25:24-28.
24. Krediet CTP, van Duje N, Linzer M, van Lieshout JJ, Wieling W: Management of vasovagal syncope: Controlling or aborting faints by leg crossing and muscle tensing. Circulation 2002;106:1684-1689.
25. Reybrouck T, Heidbuchel H, Van de Werf F, Ector H: Tilt training: A treatment for malignant and recurrent neurocardiogenic syncope. Pacing Clin Electrophysiol 2000;23:493-498.
26. Ventura R, Maas R, Ruppel R, Stuhr U, Schuchert A, Meinertz T, Nienaber CA: Psychiatric conditions in patients with recurrent unexplained syncope. Europace 2001;3:311-316.
27. Kouakam C, Lacroix D, Klug D, Baux P, Marquie C, Kacet S: Prevalence and prognostic significance of psychiatric disorders in patients evaluated for recurrent unexplained syncope. Am J Cardiol 2002;89:530-535.
28. McGrady A, Kern-Buell C, Bush E, Khuder S, Grubb BP: Psychological and physiological factors associated with tilt table testing for neurally mediated syncopal syndromes. Pacing Clin Electrophysiol 2001;24:296-301.
29. Cohen TJ, Thayapran N, Ibrahim B, Quan C, Quan W, von zur Muhlen F: An association between anxiety and neurocardiogenic syncope during head-up tilt table testing. Pacing Clin Electrophysiol 2000;23:837-841.
30. Davis SD, Kator SF, Wonnett JA, Pappas BL, Sall JL: Neurally mediated hypotension in fatigued Gulf War veterans: A preliminary report. Am J Med Sci 2000;319:89-95.
31. Khurana RK, Lynch JJ, Craig FW: A novel psychophysiological treatment for vasovagal syncope. Clin Auton Res 1997;7:191-197.
32. McGrady AV, Bush EG, Grubb BP: Outcome of biofeedback-assisted relaxation for neurocardiogenic syncope and headache: A clinical replication series. Appl Psychophysiol Biofeedback 1997;22:63-72.
33. Connolly SJ, Sheldon R, Thorpe KE, Roberts RS, Ellenbogen KA, Wilkoff BL, Morillo CO, Gent M; VPS II Investigators: Pacemaker therapy for prevention of syncope in patients with recurrent severe vasovagal syncope. Second Vasovagal Pacemaker Study (VPS II): A randomized trial. JAMA 2003;289:2224-2249.